Cyanotech Corporation

CYAN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-1.2M $-4.4M $-24.0K $-420.0K $4.2M $3.6M $1.7M $1.4M
Depreciation & Amortization $2.0M $1.5M $1.2M $1.1M $847.0K $695.0K $617.0K $512.0K
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $232.0K $665.0K $741.0K $770.0K $730.0K $453.0K $74.0K $-65.0K
Net Cash from Operating Activities $1.2M $745.0K $1.2M $2.1M $1.9M $5.1M $1.7M $1.2M
Investing Activities
Capital Expenditures $847.0K $4.3M $4.2M $4.1M $3.9M $2.0M $514.0K $1.0M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-847.0K $-3.8M — — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-206.0K $2.1M — — — — — —
Net Change in Cash $167.0K $-986.0K — — — — — —
Free Cash Flow $373.0K $-3.6M $-3.0M $-2.0M $-2.0M $3.1M $1.2M $187.0K
← Newer Page 2 of 2 Older →